Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...
The key opportunities in the Global Personalized Medicine Biomarkers Market include advancements in genomic sequencing, growing reliance on targeted therapies, rising cancer and chronic disease ...
IRVING, Texas, Aug. 13, 2025 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, published results in ...
A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Routine newborn screening (NBS) has transformed early disease ...
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma A retrospective cohort study was conducted at Chris ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...
We enrolled 50 patients undergoing resection of newly diagnosed (n = 15) or recurrent (n = 35) GBM. CSF was collected intraoperatively via the subarachnoid space (n = 25) or lateral ventricle (n = 25) ...
A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Every year, millions of newborns undergo routine screening as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results